Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The PIO III Study: In-office Placement of a Steroid-Eluting Implant Immediately Following Ethmoid Sinus Surgery

NCT02687438 is registered in ClinicalTrials.gov with ENT and Allergy Associates, LLP as lead sponsor.

NCT NCT02687438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02687438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The PIO III Study: In-office Placement of a Steroid-Eluting Implant Immediately Following Ethmoid Sinus Surgery
Lead sponsor
ENT and Allergy Associates, LLP
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2015
Completion date
February 29, 2016
Enrollment
20 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chronic sinusitis